Explore

Rapid Read Rapid Read
Texas A Researchers Develop Nasal Spray to Reverse Brain Aging, Offering Hope for Dementia Patients

Texas A Researchers Develop Nasal Spray to Reverse Brain Aging, Offering Hope for Dementia Patients

Researchers at Texas A&M University have developed a nasal spray that shows promise in reversing age-related brain inflammation, a condition linked to cognitive decline and diseases such as Alzheimer's. The study, led by Dr. Ashok Shetty and his team, demonstrated that the treatment could reduce inflammation, restore cellular energy, and improve memory in subjects. The nasal spray utilizes extracellular vesicles (EVs) to deliver microRNAs directly to the brain, bypassing the blood-brain barrier. This innovative approach has shown rapid and lasting cognitive benefits, with improvements noted within weeks and sustained over months. The treatment's effectiveness across genders is particularly noteworthy, as it is uncommon in biomedical research. The team has filed a U.S. patent for the therapy, highlighting its potential to transform how neurodegenerative diseases are treated.
Trendline Trendline
Study Finds Loneliness May Affect Memory in Older Adults Without Accelerating Cognitive Decline

Study Finds Loneliness May Affect Memory in Older Adults Without Accelerating Cognitive Decline

Study Finds Loneliness May Affect Memory in Older Adults Without Accelerating Cognitive Decline
Rapid Read Rapid Read
Study Reveals Potential Brain Risks of Fish Oil Supplements

Study Reveals Potential Brain Risks of Fish Oil Supplements

A new study from the Medical University of South Carolina has raised concerns about the effects of fish oil supplements on brain health, particularly in individuals with repeated mild traumatic brain injuries. The research, published in Cell Reports, suggests that eicosapentaenoic acid (EPA), a component of fish oil, may impair the brain's ability to recover from such injuries. This challenges the common perception that omega-3 supplements are universally beneficial. The study highlights the need for a nuanced understanding of how these supplements interact with brain biology, as their effects may vary depending on individual health conditions and the context of use.
Trendline Trendline
Research Links Diet to Parkinson's Risk Reduction

Research Links Diet to Parkinson's Risk Reduction

Research Links Diet to Parkinson's Risk Reduction
Trendline Trendline
Study Finds Loneliness Impacts Memory in Older Adults Without Accelerating Decline

Study Finds Loneliness Impacts Memory in Older Adults Without Accelerating Decline

Study Finds Loneliness Impacts Memory in Older Adults Without Accelerating Decline
Trendline Trendline
New Research Reveals Brain's Role in Metformin's Diabetes Treatment

New Research Reveals Brain's Role in Metformin's Diabetes Treatment

New Research Reveals Brain's Role in Metformin's Diabetes Treatment
Rapid Read Rapid Read
New Study Suggests Alzheimer's Memory Loss May Be Partially Reversible

New Study Suggests Alzheimer's Memory Loss May Be Partially Reversible

A recent study conducted by researchers at the Medical Faculty of the University Hospital Magdeburg has revealed that memory loss in Alzheimer's patients may not be solely due to the loss of nerve cells. The study, published in Nature Reviews Neurology, indicates that disruptions in brain network functions could also contribute to memory impairments. This finding suggests that some memory losses might be reversible if the brain's network functions are restored. The research highlights the potential for therapies that focus on enhancing brain network functions, such as targeted memory training and stimulation of brain areas, to improve memory performance in Alzheimer's patients.
Rapid Read Rapid Read
Study Suggests Alzheimer's May Originate in Peripheral Nerves, Not Just the Brain

Study Suggests Alzheimer's May Originate in Peripheral Nerves, Not Just the Brain

Researchers at the University of Central Florida have discovered that some movement-related symptoms of Alzheimer's disease may originate in the peripheral nervous system rather than solely in the brain. Using 'human-on-a-chip' technology, the study demonstrated that genetic mutations associated with familial Alzheimer's can directly damage the connection between nerves and muscles, independent of the brain or spinal cord. This finding challenges the traditional understanding that Alzheimer's symptoms are primarily due to brain degeneration. The study was supported by the National Institutes of Health and highlights the potential for new diagnostic and treatment approaches for Alzheimer's disease.
Rapid Read Rapid Read
Researchers Achieve Breakthrough in Cryogenic Brain Tissue Recovery

Researchers Achieve Breakthrough in Cryogenic Brain Tissue Recovery

In a groundbreaking study, researchers have successfully demonstrated that frozen brain tissue from mice can return to normal function after being subjected to extremely cold conditions. The study, conducted by a team of German scientists, involved cooling slices of mouse hippocampal tissue, which is associated with memory and learning, to minus 196 degrees Celsius. The findings revealed that the neurons and synapses necessary for learning and memory maintained their structural integrity and resumed normal activity after rewarming. This research suggests that brain tissue is more resilient than previously believed, extending its tolerance from hypothermic to cryogenic states. The study, published in the Proceedings of the National Academy of Sciences, marks a significant step towards the possibility of human hibernation, which could have applications in space travel.
Trendline Trendline
Texas A Projected as Regional Host in NCAA Baseball Tournament

Texas A Projected as Regional Host in NCAA Baseball Tournament

Texas A Projected as Regional Host in NCAA Baseball Tournament
Trendline Trendline
ONWARD Medical Secures €40.6 Million to Advance Spinal Cord Stimulation Implant

ONWARD Medical Secures €40.6 Million to Advance Spinal Cord Stimulation Implant

ONWARD Medical Secures €40.6 Million to Advance Spinal Cord Stimulation Implant
Trendline Trendline
ONWARD Medical Secures €40.6M to Advance Spinal Cord Stimulation Implant Trials

ONWARD Medical Secures €40.6M to Advance Spinal Cord Stimulation Implant Trials

ONWARD Medical Secures €40.6M to Advance Spinal Cord Stimulation Implant Trials